Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| DOHH-2 | IC50 | 35.1 μM | Antiproliferative activity against human DOHH2 cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay | [PMID: 31895575] |
| Farage | IC50 | 33.9 μM | Antiproliferative activity against human Farage cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay | [PMID: 31895575] |
| L02 | IC50 | > 100 μM | Cytotoxicity against human LO2 cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay | [PMID: 31895575] |
| NCM460 | IC50 | > 100 μM | Cytotoxicity against human NCM460 cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay | [PMID: 31895575] |
| OCI-Ly7 | IC50 | 39 μM | Antiproliferative activity against human OCI-LY7 cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay | [PMID: 31895575] |
| PNT1A | IC50 | > 100 μM | Cytotoxicity against human PNT1A cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay | [PMID: 31895575] |
| SUD4 | IC50 | 51.3 μM | Antiproliferative activity against human SUDHL4 cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay | [PMID: 31895575] |
| Toledo | IC50 | 65.3 μM | Antiproliferative activity against BCL6-negative human Toledo cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay | [PMID: 31895575] |